Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 25:22:5116-5123.
doi: 10.12659/msm.899114.

Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG)

Affiliations

Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG)

Peijun Tian et al. Med Sci Monit. .

Abstract

BACKGROUND This study was aimed to reveal the role of miR-149-5p in acute myeloid leukemia (AML) cells apoptosis and the possible mechanism involved. MATERIAL AND METHODS The expression of miR-149-5p in leukemia cell lines, as well as the blood and bone marrow (BM) samples from leukemia patients, were monitored by reverse-transcription polymerase chain reaction (RT-PCR). AML cell line THP-1 was transfected with miR-149-5p mimic or inhibitor, and then cell apoptosis was determined using the APO Percentage assay kit. The target of miR-149-5p was predicted by using the microRNA.org database, and verified by RT-PCR, Western blot, and Dual-Luciferase reporter assays. Further, small interfering RNA (siRNA) against the target gene was co-transfected with miR-149-5p inhibitor, and then the cell apoptosis and the expression of apoptosis-related proteins were assessed. RESULTS MiR-149-5p was significantly up-regulated in leukemia cell lines and samples from leukemia patients (P<0.01 or P<0.001), especially in THP-1 cells and samples from AML patients. Cell apoptosis was significantly decreased by miR-149-5p overexpression (P<0.01) and increased by miR-149-5p suppression (P<0.05). Fas Ligand (FASLG) was a direct target of miR-149-5p, and was negatively regulated by miR-149-5p. More importantly, the inductive effects of miR-149-5p suppression on cell apoptosis were abrogated by si-FASLG (P<0.01). Furthermore, the up-regulative effects of miR-149-5p suppression on the phosphorylated form of Fas-associated via death domain (p-FADD), caspase-8, caspase-2, caspase-3, and the cleaved forms of these caspases were abrogated by si-FASLG. CONCLUSIONS Inhibition of miR-149-5p can induce apoptosis in THP-1 cells. These inductive effects might be via targeting FASLG and activating FADD and caspases.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Relative miR-149-5p expression at mRNA level in leukemia cell lines and the BM and blood samples from leukemia patients. The miR-149-5p expression at mRNA level in 3 leukemia cell lines, THP-1, Molt-4, and K562 was measured by RT-PCR analysis (A). The mRNA level of miR-149-5p expression was detected in the BM samples (B) and fresh blood (C) from 3 types of leukemia: AML, T-ALL, and CML. BM – bone marrow; RT-PCR – real-time reverse transcription polymerase chain reaction; AML – acute myeloid leukemia; T-ALL – T cell acute lymphoblastic leukemia; CML – chronic myeloid leukemia; ** P<0.01; *** P<0.001.
Figure 2
Figure 2
Inhibition of miR-149-5p induced THP-1 cells apoptosis. MiR-149-5p mimic or inhibitor was transfected into THP-1 cells, and the efficiency of transfection was detected by RT-PCR analysis (A). Afterward, cell apoptosis was measured by using APO Percentage assay kit (B). RT-PCR – real-time reverse transcription polymerase chain reaction; * P<0.05; ** P<0.01; *** P<0.001.
Figure 3
Figure 3
FASLG was predicted and verified as a direct target of miR-149-5p. The microRNA.org database was used to predict the target gene of miR-149-5p (A). The mRNA and protein level of FASLG expression in miR-149-5p overexpressed cells or miR-149-5p suppressed cells were detected by RT-PCR (B) and Western blot (C). Dual-Luciferase reporter assay was performed to confirm miR-149-5p targeted the 3′-UTR of FASLG (D). FASLG – Fas ligand; RT-PCR – real-time reverse transcription polymerase chain reaction; 3′-UTR – 3′-untranslated region; ** P<0.01; *** P<0.001.
Figure 4
Figure 4
Inhibition of miR-149-5p induced cell apoptosis via targeting FASLG. si-FASLG or its negative control was transfected into THP-1 cells, and then the mRNA level of FASLG expression was measured by RT-PCR (A). si-FASLG or/and miR-149-5p inhibitor were transfected into THP-1 cells, and the expression of FASLG protein was detected by Western blot (B). si-FASLG or/and miR-149-5p inhibitor were transfected into THP-1 cells, and the cell apoptosis was determined using the APO Percentage assay kit (C). FASLG – Fas ligand; RT-PCR – real-time reverse transcription polymerase chain reaction; ** P<0.01; *** P<0.001.
Figure 5
Figure 5
MiR-149-5p targeted FASLG and activated FADD and caspases. si-FASLG or/and miR-149-5p inhibitor were transfected into THP-1 cells, and then the protein expressions of p-FADD, FADD, caspase-8, cleaved caspase-8, caspase-2, cleaved caspase-2, caspase-3, and cleaved caspase-3 were determined by Western blot. FASLG – Fas ligand; FADD – Fas-associated via death domain.

Similar articles

Cited by

References

    1. Gocek E, Ewa M. Differentiation therapy of acute myeloid leukemia. Cancers. 2011;3:2402–20. - PMC - PubMed
    1. Hoffbrand A, Moss P, Pettit J. Essential Haematolog. 5th ed. Oxford, United Kingdom, UK: Blackwell Publishing; 2006.
    1. O’Donnell MR, Tallman MS, Abboud CN, et al. Acute myeloid leukemia, version 2.2013. J Natl Compr Canc Netw. 2013;11:1047–55. - PMC - PubMed
    1. Malinowska I, Stelmaszczyk-Emmel A, Wasik M, Rokicka-Milewska R. Apoptosis and pH of blasts in acute childhood leukemia. Med Sci Monit. 2002;8(6):CR441–47. - PubMed
    1. Walter RB, Othus M, Burnett AK, et al. Resistance prediction in AML: Analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia. 2015;29:312–20. - PMC - PubMed

MeSH terms